vs
Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and Cronos Group Inc. (CRON). Click either name above to swap in a different company.
Cronos Group Inc. is the larger business by last-quarter revenue ($44.5M vs $43.2M, roughly 1.0× ADAMAS TRUST, INC.). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -4.1%, a 128.1% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs 47.0%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $9.7M). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs 32.7%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
ADAM vs CRON — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.2M | $44.5M |
| Net Profit | $53.5M | $-1.8M |
| Gross Margin | — | 36.4% |
| Operating Margin | — | -16.8% |
| Net Margin | 124.0% | -4.1% |
| Revenue YoY | 61.6% | 47.0% |
| Net Profit YoY | 270.5% | -104.2% |
| EPS (diluted) | $0.45 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.2M | $44.5M | ||
| Q3 25 | $36.6M | $36.3M | ||
| Q2 25 | $36.4M | $33.5M | ||
| Q1 25 | $33.1M | $32.3M | ||
| Q4 24 | $26.7M | $30.3M | ||
| Q3 24 | $20.2M | $34.3M | ||
| Q2 24 | $19.0M | $27.8M | ||
| Q1 24 | $17.9M | $25.3M |
| Q4 25 | $53.5M | $-1.8M | ||
| Q3 25 | $44.8M | $26.0M | ||
| Q2 25 | $8.5M | $-39.7M | ||
| Q1 25 | $42.2M | $6.1M | ||
| Q4 24 | $-31.4M | $43.7M | ||
| Q3 24 | $42.8M | $8.3M | ||
| Q2 24 | $-15.6M | $-8.8M | ||
| Q1 24 | $-57.9M | $-2.2M |
| Q4 25 | — | 36.4% | ||
| Q3 25 | — | 50.4% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 42.6% | ||
| Q4 24 | — | 35.7% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 17.7% |
| Q4 25 | — | -16.8% | ||
| Q3 25 | — | -1.4% | ||
| Q2 25 | 11.7% | -15.9% | ||
| Q1 25 | — | -12.6% | ||
| Q4 24 | -119.0% | -37.5% | ||
| Q3 24 | — | -98.2% | ||
| Q2 24 | -124.7% | -56.1% | ||
| Q1 24 | -448.8% | -63.1% |
| Q4 25 | 124.0% | -4.1% | ||
| Q3 25 | 122.5% | 71.4% | ||
| Q2 25 | 23.4% | -118.7% | ||
| Q1 25 | 127.4% | 19.0% | ||
| Q4 24 | -117.5% | 144.3% | ||
| Q3 24 | 211.7% | 24.4% | ||
| Q2 24 | -81.9% | -31.5% | ||
| Q1 24 | -324.1% | -8.9% |
| Q4 25 | $0.45 | $-0.01 | ||
| Q3 25 | $0.36 | $0.07 | ||
| Q2 25 | $-0.04 | $-0.10 | ||
| Q1 25 | $0.33 | $0.02 | ||
| Q4 24 | $-0.46 | $0.12 | ||
| Q3 24 | $0.36 | $0.02 | ||
| Q2 24 | $-0.29 | $-0.02 | ||
| Q1 24 | $-0.75 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.3M | $831.8M |
| Total DebtLower is stronger | $735.8M | — |
| Stockholders' EquityBook value | $1.4B | $1.1B |
| Total Assets | $12.6B | $1.2B |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.3M | $831.8M | ||
| Q3 25 | $185.3M | $824.2M | ||
| Q2 25 | $160.4M | $834.4M | ||
| Q1 25 | $177.1M | $837.8M | ||
| Q4 24 | $167.4M | $858.8M | ||
| Q3 24 | $195.1M | $862.0M | ||
| Q2 24 | $235.5M | $848.2M | ||
| Q1 24 | $226.9M | $855.1M |
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | — | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | — | ||
| Q4 24 | $573.2M | — | ||
| Q3 24 | $699.4M | — | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | — |
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.4B | $1.1B | ||
| Q1 24 | $1.5B | $1.1B |
| Q4 25 | $12.6B | $1.2B | ||
| Q3 25 | $12.4B | $1.2B | ||
| Q2 25 | $10.6B | $1.2B | ||
| Q1 25 | $10.0B | $1.2B | ||
| Q4 24 | $9.2B | $1.2B | ||
| Q3 24 | $8.9B | $1.2B | ||
| Q2 24 | $8.2B | $1.1B | ||
| Q1 24 | $7.4B | $1.1B |
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.0M | $11.8M |
| Free Cash FlowOCF − Capex | $125.9M | $9.7M |
| FCF MarginFCF / Revenue | 291.6% | 21.8% |
| Capex IntensityCapex / Revenue | 18.9% | 4.8% |
| Cash ConversionOCF / Net Profit | 2.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $149.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.0M | $11.8M | ||
| Q3 25 | $6.9M | $13.3M | ||
| Q2 25 | $39.2M | $2.8M | ||
| Q1 25 | $25.8M | $-2.1M | ||
| Q4 24 | $14.1M | $7.7M | ||
| Q3 24 | $-922.0K | $11.6M | ||
| Q2 24 | $-993.0K | $1.7M | ||
| Q1 24 | $-13.1M | $-2.2M |
| Q4 25 | $125.9M | $9.7M | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-17.4M | ||
| Q4 24 | $-10.6M | $4.2M | ||
| Q3 24 | $-8.6M | $5.2M | ||
| Q2 24 | $-8.6M | $1.0M | ||
| Q1 24 | $-19.1M | $-3.9M |
| Q4 25 | 291.6% | 21.8% | ||
| Q3 25 | — | 24.3% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | -53.8% | ||
| Q4 24 | -39.6% | 13.8% | ||
| Q3 24 | -42.3% | 15.1% | ||
| Q2 24 | -44.9% | 3.7% | ||
| Q1 24 | -107.0% | -15.5% |
| Q4 25 | 18.9% | 4.8% | ||
| Q3 25 | — | 12.3% | ||
| Q2 25 | — | 11.5% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | 92.3% | 11.7% | ||
| Q3 24 | 37.7% | 18.7% | ||
| Q2 24 | 39.7% | 2.6% | ||
| Q1 24 | 33.5% | 6.8% |
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | 0.51× | ||
| Q2 25 | 4.59× | — | ||
| Q1 25 | 0.61× | -0.34× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | -0.02× | 1.39× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
